Kirk AD - Search Results

1

Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients.

Kirk AD, Adams AB, Durrbach A, Ford ML, Hildeman DA, Larsen CP, Vincenti F, Wojciechowski D, Woodle ES. Kirk AD, et al. Am J Transplant. 2021 May;21(5):1691-1698. doi: 10.1111/ajt.16386. Epub 2020 Nov 24. Am J Transplant. 2021. PMID: 33128812 Free PMC article.

2

Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance.

Kirk AD, Ibrahim MA, Bollinger RR, Dawson DV, Finn OJ. Kirk AD, et al. Transplantation. 1992 Feb;53(2):329-38. doi: 10.1097/00007890-199202010-00014. Transplantation. 1992. PMID: 1371194

3

Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients.

Cho CS, Burkly LC, Fechner JH Jr, Kirk AD, Oberley TD, Dong Y, Brunner KG, Peters D, Tenhoor CN, Nadeau K, Yagci G, Ishido N, Schultz JM, Tsuchida M, Hamawy MM, Knechtle SJ. Cho CS, et al. Among authors: kirk ad. Transplantation. 2001 Aug 27;72(4):587-97. doi: 10.1097/00007890-200108270-00006. Transplantation. 2001. PMID: 11544416

4

Effect of donor factors on early graft survival in adult cadaveric renal transplantation.

Swanson SJ, Hypolite IO, Agodoa LY, Batty DS Jr, Hshieh PB, Cruess D, Kirk AD, Peters TG, Abbott KC. Swanson SJ, et al. Among authors: kirk ad. Am J Transplant. 2002 Jan;2(1):68-75. doi: 10.1034/j.1600-6143.2002.020112.x. Am J Transplant. 2002. PMID: 12095059 Free article.

5

Strategies for minimizing immunosuppression in kidney transplantation.

Kirk AD, Mannon RB, Swanson SJ, Hale DA. Kirk AD, et al. Transpl Int. 2005 Jan;18(1):2-14. doi: 10.1111/j.1432-2277.2004.00019.x. Transpl Int. 2005. PMID: 15612977 Free article. Review.

6

Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.

Pearl JP, Parris J, Hale DA, Hoffmann SC, Bernstein WB, McCoy KL, Swanson SJ, Mannon RB, Roederer M, Kirk AD. Pearl JP, et al. Among authors: kirk ad. Am J Transplant. 2005 Mar;5(3):465-74. doi: 10.1111/j.1600-6143.2005.00759.x. Am J Transplant. 2005. PMID: 15707400 Free article.

7

Functionally significant renal allograft rejection is defined by transcriptional criteria.

Hoffmann SC, Hale DA, Kleiner DE, Mannon RB, Kampen RL, Jacobson LM, Cendales LC, Swanson SJ, Becker BN, Kirk AD. Hoffmann SC, et al. Among authors: kirk ad. Am J Transplant. 2005 Mar;5(3):573-81. doi: 10.1111/j.1600-6143.2005.00719.x. Am J Transplant. 2005. PMID: 15707413 Free article.

8

IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.

Preston EH, Xu H, Dhanireddy KK, Pearl JP, Leopardi FV, Starost MF, Hale DA, Kirk AD. Preston EH, et al. Among authors: kirk ad. Am J Transplant. 2005 May;5(5):1032-41. doi: 10.1111/j.1600-6143.2005.00796.x. Am J Transplant. 2005. PMID: 15816883 Free article.

9

Transplant tolerance: converging on a moving target.

Newell KA, Larsen CP, Kirk AD. Newell KA, et al. Among authors: kirk ad. Transplantation. 2006 Jan 15;81(1):1-6. doi: 10.1097/01.tp.0000179149.12979.13. Transplantation. 2006. PMID: 16421467 Review.

10

A new look at blockade of T-cell costimulation: a therapeutic strategy for long-term maintenance immunosuppression.

Larsen CP, Knechtle SJ, Adams A, Pearson T, Kirk AD. Larsen CP, et al. Among authors: kirk ad. Am J Transplant. 2006 May;6(5 Pt 1):876-83. doi: 10.1111/j.1600-6143.2006.01259.x. Am J Transplant. 2006. PMID: 16611323 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page